Epigenetic resensitization to platinum in recurrent, platinum-resistant ovarian cancer (OC) using guadecitabine (SGI-110), a novel hypomethylating agent (HMA): Results of a randomized phase II study.
暂无分享，去创建一个
D. Matei | A. Oza | D. Provencher | J. Nemunaitis | H. Hirte | A. Secord | U. Matulonis | G. Fleming | M. Markham | H. Keer | L. Roman | R. Kristeleit | S. Blagden | M. Azab | B. Basu | J. Elkas | S. Ghamande | S. Banerjee | S. Naim | Y. Hao